Monday, November 29, 2010

Metformin fifteen years later

Since this original NEJM review metformin has turned out to be better and safer than we anticipated. Early fears were driven by the dismal track record of its cousin phenformin. Lactic acidosis is rare and heart failure no longer seems to be a contraindication according to this recent review. After 15 years it looks like a keeper.

No comments: